119 related articles for article (PubMed ID: 19709359)
1. Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.
Omland LH; Jepsen P; Weis N; Christensen PB; Laursen AL; Nielsen H; Krarup H; Sørensen HT; Obel N
J Viral Hepat; 2010 Apr; 17(4):261-8. PubMed ID: 19709359
[TBL] [Abstract][Full Text] [Related]
2. Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.
Larsen MV; Omland LH; Gerstoft J; Larsen CS; Jensen J; Obel N; Kronborg G
Addiction; 2010 Mar; 105(3):529-35. PubMed ID: 20402997
[TBL] [Abstract][Full Text] [Related]
3. Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.
Omland LH; Krarup H; Jepsen P; Georgsen J; Harritshøj LH; Riisom K; Jacobsen SE; Schouenborg P; Christensen PB; Sørensen HT; Obel N;
J Hepatol; 2010 Jul; 53(1):36-42. PubMed ID: 20400197
[TBL] [Abstract][Full Text] [Related]
4. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study.
Omland LH; Jepsen P; Skinhøj P; Jørgensen HL; Münster AM; Bangsborg J; Fenger M; Sørensen HT; Obel N
HIV Med; 2009 Feb; 10(2):65-71. PubMed ID: 19018878
[TBL] [Abstract][Full Text] [Related]
5. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
[TBL] [Abstract][Full Text] [Related]
6. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
Shores NJ; Maida I; Soriano V; Núnez M
J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
[TBL] [Abstract][Full Text] [Related]
7. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
8. Mortality in siblings of patients coinfected with HIV and hepatitis C virus.
Hansen AB; Gerstoft J; Kronborg G; Pedersen C; Sorensen HT; Obel N
J Infect Dis; 2007 Jan; 195(2):230-5. PubMed ID: 17191168
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus reinfection in injection drug users.
Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
Soriano V; Mocroft A; Rockstroh J; Ledergerber B; Knysz B; Chaplinskas S; Peters L; Karlsson A; Katlama C; Toro C; Kupfer B; Vogel M; Lundgren J;
J Infect Dis; 2008 Nov; 198(9):1337-44. PubMed ID: 18767985
[TBL] [Abstract][Full Text] [Related]
11. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
Mohsen AH; Murad S; Easterbrook PJ
HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
[TBL] [Abstract][Full Text] [Related]
13. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
14. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ
J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121
[TBL] [Abstract][Full Text] [Related]
15. Comparative mortality in HIV-infected patients in Denmark, 1995-2005.
Singer RB; Milano AF
J Insur Med; 2008; 40(2):116-9. PubMed ID: 19119590
[TBL] [Abstract][Full Text] [Related]
16. Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.
Clausen LN; Weis N; Schønning K; Fenger M; Krarup H; Bukh J; Benfield T
Scand J Infect Dis; 2011 Oct; 43(10):798-803. PubMed ID: 21728744
[TBL] [Abstract][Full Text] [Related]
17. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
[TBL] [Abstract][Full Text] [Related]
18. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
[TBL] [Abstract][Full Text] [Related]
19. [Chronic hepatitis B and C in HIV-infected patients].
Opravil M; Hunziker R; Lüthy R; Grob PJ
Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
